Exact Mass: 412.0185164

Exact Mass Matches: 412.0185164

Found 106 metabolites which its exact mass value is equals to given mass value 412.0185164, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

pyraflufen

Pyraflufen-ethyl

C15H13Cl2F3N2O4 (412.02044340000003)

CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9709; ORIGINAL_PRECURSOR_SCAN_NO 9708 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9657; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9632; ORIGINAL_PRECURSOR_SCAN_NO 9630 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9674; ORIGINAL_PRECURSOR_SCAN_NO 9672 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9681; ORIGINAL_PRECURSOR_SCAN_NO 9679 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9708; ORIGINAL_PRECURSOR_SCAN_NO 9706

Imazosulfuron

C14H13ClN6O5S (412.03566380000007)

Precursor ion, [M-H]-, is a 37Cl-isotopolog ion.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.

dIDP

{[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-2-yl]methoxy})phosphoryl]oxy}phosphonic acid

C10H14N4O10P2 (412.0185164)

dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050) [HMDB] dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050).

Obtusol

C15-H23-Br2-Cl-O

C15H23Br2ClO (411.9804058)

1-(5-O-phosphono-beta-D-ribofuranosyl)-3,5-bis(sulfanylcarbonyl)pyridin-1-ium

C12H15NO9PS2+ (411.992585)

Nitrofenac

2-((2,6-Dichlorophenyl) amino)benzeneacetate-4-hydroxybutylnitric ester

C18H18Cl2N2O5 (412.05927180000003)

Thiamphenicol glycinate

N-{3-[(2-aminoacetyl)oxy]-1-hydroxy-1-(4-methanesulphonylphenyl)propan-2-yl}-2,2-dichloroethanimidic acid

C14H18Cl2N2O6S (412.02625880000005)

Opicapone

2,5-dichloro-3-[5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl]-4,6-dimethylpyridin-1-ium-1-olate

C15H10Cl2N4O6 (411.997738)

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

Patuletin 7-O-sulfate

3,5,7,3,4-Pentahydroxy-6-methoxyflavon 7-O-sulfate

C16H12O11S (412.0100322)

ZINC2147628

C17H16O8S2 (412.0286576)

Maybridge4_002233

C16H13ClN2O3S3 (411.9776818000001)

LEOIDIN

C18H14Cl2O7 (412.0116554)

GANGALEOIDIN

C18H14Cl2O7 (412.0116554)

Patuletin 3-O-sulfate

C16H12O11S (412.0100322)

spiroxin A

C20H9ClO8 (411.9985944)

14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoic acid|xestospongiene R

C14H22Br2O4 (411.9884732)

C20H12O10

C20H12O10 (412.0430452)

LEOIDIN

NCGC00095464-02!LEOIDIN

C18H14Cl2O7 (412.0116554)

Pyrafluefen-ethyl

C15H13Cl2F3N2O4 (412.02044340000003)

Leoidin_major

C18H14Cl2O7 (412.0116554)

dichloropalladium,triethylphosphane

C12H30Cl2P2Pd (412.023445)

1h,1h,9h,9h-perfluoro-1,9-nonanediol

C9H6F14O2 (412.0144224)

1H,1H,1H-PENTADECAFLUORO-2-NONANONE

C9H3F15O (411.9944368)

Methyl 5-iodo-2-(2-(methoxycarbonyl)phenoxy)benzoate

C16H13IO5 (411.9807718)

Benzenesulfonamide,N-(3-bromopropyl)-4-methyl-N-(4-nitrophenyl)-

C16H17BrN2O4S (412.00923420000004)

diisopropylbis(trifluoromethanesulfonyl)silane

C8H14F6O6S2Si (411.99052559999996)

Triphenylsulfonium trifluoromethanesulfonate

C19H15F3O3S2 (412.0414676)

Ethyl viologen diperchlorate

C14H18Cl2N2O8 (412.0440168)

thiamphenicol

Thiamphenicol glycinate

C14H18Cl2N2O6S (412.02625880000005)

ethyl 6-broMo-1,5-diMethyl-2-(2-nitroethyl)-1H-indole-3-carboxylate coMpound with Methanedione (1:1)

C16H17BrN2O6 (412.0269922)

2-[[4-[3-(4,5-dichloro-2-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethanol

C18H18Cl2N2O3S (412.0415138000001)

[4,4,5,5,6,7,7,7-octafluoro-2-hydroxy-6-(trifluoromethyl)heptyl] 2-methylprop-2-enoate

C12H11F11O3 (412.0532508)

Oregon green 488 carboxylate

C21H10F2O7 (412.0394574)

2-(2,2-Dichloroacetamido)-3-hydroxy-3-[4-(methanesulfonyl)phenyl]propyl glycinate

C14H18Cl2N2O6S (412.02625880000005)

Trifludimoxazin

C16H11F3N4O4S (412.0453082)

Sulbenicillin(2-)

C16H16N2O7S2-2 (412.0398906)

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)

C16H16N2O9S-2 (412.0576486)

(E)-N-[N-(5-Methyl-3-phenyl-isoxazole-4-carbonyl)-hydrazinocarbothioyl]-3-thiophen-2-yl-acrylamide

C19H16N4O3S2 (412.06637859999995)

3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxybenzoic acid

C13H16O13S (412.0311606)

(3S,4R,6R,9R,10R)-4,9-Dibromo-10-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804058)

methyl 8-[(2E)-2-[(6-bromo-1,3-benzodioxol-5-yl)methylidene]hydrazinyl]-8-oxooctanoate

C17H21BrN2O5 (412.06337560000003)

Temocillin(2-)

C16H16N2O7S2-2 (412.0398906)

[2-Hydroxy-5-(3,5,7-trihydroxy-6-methoxy-4-oxochromen-2-yl)phenyl] hydrogen sulate

C16H12O11S (412.0100322)

(3S,4R,5S)-4-(tert-Butyldimethylsilyloxy)-1,1-dibromo-3,5-dimethyl-1-heptene

C15H30Br2OSi (412.043253)

2-Deoxyinosine-5-diphosphate

C10H14N4O10P2 (412.0185164)

A deoxyinosine phosphate compound having a diphosphate group at the 5-position.

Opicapone

C15H10Cl2N4O6 (411.997738)

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)

C16H16N2O9S (412.0576486)

Dicarboxylate anion of (7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate acid.

Sulbenicillin(2-)

C16H16N2O7S2 (412.0398906)

Temocillin(2-)

C16H16N2O7S2 (412.0398906)

A 839977

C19H14Cl2N6O (412.0606094)

A 839977 is a P2X7 selective antagonist; it blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20 nM, 42 nM and 150 nM respectively) and reduces inflammatory and neuropathic pain in animal models; the antihyperalgesic effects of P2X7 receptor blockade are mediated by blocking the release of IL-1beta[1].

methyl 13,15-dichloro-14-hydroxy-6-methoxy-4,12-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-5-carboxylate

C18H14Cl2O7 (412.0116554)

methyl 13,15-dichloro-6,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylate

C18H14Cl2O7 (412.0116554)